Xin Huang
Financieel Directeur/CFO bij PharmaLegacy Laboratories (Shanghai) Co., Ltd.
Oorsprong van het eerstegraads netwerk van Xin Huang
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China.
12
| Holding Company | Miscellaneous Commercial Services | 12 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Xin Huang via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Tongji University | College/University | Corporate Officer/Principal Graduate Degree | |
| CELLULAR BIOMEDICINE GROUP, INC. | Biotechnology | Director/Board Member | |
Genor Biopharma Co., Ltd.
 Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
| Nanjing University | College/University | Graduate Degree | |
| Australian National University | College/University | Graduate Degree | |
| Shanghai Institute of Pharmaceutical Industry | College/University | Graduate Degree | |
| Université Pierre-Mendès-France | College/University | Masters Business Admin | |
| Shanghai University | College/University | Undergraduate Degree | |
| Hebei University of Technology | College/University | Masters Business Admin | |
| China Pharmaceutical University | College/University | Graduate Degree | |
| The University of Waterloo | College/University | Undergraduate Degree | |
| Shanghai International Studies University | College/University | Graduate Degree | |
| Tianjin Medical University | College/University | Graduate Degree | |
| GEMPHARMATECH CO., LTD. | Biotechnology | Director/Board Member | |
| SUZHOU NANOMICRO TECHNOLOGY CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
| Yale University | College/University | Graduate Degree | |
| Stanford University | College/University | Graduate Degree | |
| Temple University School of Medicine | College/University | Corporate Officer/Principal | |
| The Hong Kong University of Science & Technology | College/University | Undergraduate Degree | |
| Shanghai Panxin Equity Investment Management Co. Ltd. | Chief Investment Officer | ||
Citigroup Global Markets Asia Ltd.
 Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Investment Banks/Brokers | Corporate Officer/Principal | |
| ZHAOKE OPHTHALMOLOGY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| GENOR BIOPHARMA HOLDINGS LIMITED | Biotechnology | Director/Board Member | |
| GRACELL BIOTECHNOLOGIES INC. | Biotechnology | Director/Board Member | |
| GUANGZHENG EYE HOSPITAL GROUP CO.,LTD. | Medical/Nursing Services | Director/Board Member | |
| ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Harbin Medical University | College/University | Undergraduate Degree | |
| Chinese Academy of Medical Sciences | College/University | Doctorate Degree | |
| Peking Union Medical College | College/University | Doctorate Degree | |
| University of North Texas Health Science Center | College/University | Doctorate Degree | |
| University of Oxford | College/University | Doctorate Degree |
Statistieken
Internationaal
| China | 20 |
| Verenigde Staten | 6 |
| Hongkong | 4 |
| Australië | 2 |
| Frankrijk | 2 |
Sectoraal
| Consumer Services | 21 |
| Health Technology | 8 |
| Commercial Services | 2 |
| Finance | 2 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 18 |
| Graduate Degree | 9 |
| Independent Dir/Board Member | 7 |
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 4 |
Sterkste connecties
| Insiders | |
|---|---|
| Guo Tong Xu | 11 |
| Yu Chen | 11 |
| Wen Jun Zhu | 3 |
| Jun Yi Li | 3 |
| Jeff Duan | 2 |
| Jun Li | 2 |
| Xin Shu | 2 |
| Sheng Xue Mou | 2 |
| Zi Chun Ding | 2 |
| Yue Chi Zhang | 2 |
| Xiao Kang Liu | 2 |
| Xu Chen Duan | 2 |
